1 / 41

Tackling HCAI in the NHS -strategy and actions

Tackling HCAI in the NHS -strategy and actions. Professor Brian Duerden Inspector of Microbiology and Infection Control, Department of Health, London . MRSA bacteraemia 2001/2 7291 (Q Av)1823 2002/3 7426 (Q Av)1856 2003/4 7700 (Q Av)1925 2004/5 7212 (Q Av)1808

liberty
Download Presentation

Tackling HCAI in the NHS -strategy and actions

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Tackling HCAI in the NHS-strategy and actions Professor Brian Duerden Inspector of Microbiology and Infection Control, Department of Health, London

  2. MRSA bacteraemia 2001/2 7291 (Q Av)1823 2002/3 7426 (Q Av)1856 2003/4 7700 (Q Av)1925 2004/5 7212 (Q Av)1808 2005/6 7097 (Q Av)1773 2006 Q1 1741 Q2 1652 Q3 1542 C. difficile infection 2001 22008 2002 28986 2003 35537 2004 43672 2005 49850 (voluntary reporting, England, Wales, NI) 2004 44314 2005 51767 2006 55681 (England, mandatory) 2007 -The challenge of HCAI

  3. Clinicians Safe patient care Diagnosis Treatment Prevention Control DIPC Corporate environment Make it happen Government/DH Set standards Ensure priority Monitor outcome Legislation Performance management Responsibility for HCAI

  4. Microbiology & Infection Control New antibiotics New societies New journals New guidelines New diseases Infection control was the province of the IC specialists Modern medicine Increased life expectancy Cancer treatment Immunosuppression Complex surgery Cardiac, Neurosurgery Orthopaedic Chronic illnesses Renal dialysis Infection – a nuisance 1970 – 2000: a dichotomy

  5. Infection is different…….…….it spreads!

  6. Biology Microbial populations Human populations Human behaviour

  7. Reducing HCAI…. Change the mindset • From: 1) create a system to deliver specialist clinical care 2) take measures to prevent infection • To: 1) create a safe environment for patient care 2) deliver specialist clinical care within that environment

  8. Getting Ahead of the Curve - 2002 Priorities identified • HCAI • bacteraemia (MRSA, GRE) • C. difficile associated diarrhoea • surgical site infection • Tuberculosis • Blood-borne & sexually transmitted viruses (and others!) • Antimicrobial resistance

  9. And then……….POLITICS(and the media hype)

  10. HCAI 2003 - 04 • Winning Ways - December 2003 • Strategy for HCAI • NAO Report - July 2004 • Critical of slow progress • Towards Cleaner Hospitals and Lower Rates of Infection - July 2004 • Action plan

  11. MRSA Target • ‘Halve MRSA infections by 2008’ • MRSA bacteraemia • Baseline 2003-04; Start date April 2005 • Monthly returns • 3-monthly publication from Jan 2007 • Depends upon mandatory surveillance being accurate and timely

  12. Healthcare Associated Infections • MRSA - not the only one! • Clostridium difficile • Glycopeptide resistant enterococci • ESBL-producing E. coli etc • Acinetobacter baumannii • Norovirus

  13. C. difficile “new superbug” hits the national press Mon. June 6th 2005. Jeremy Laurance – Health Editor, The Independent

  14. The 1994 DH/PHLS Report (North Manchester outbreak of 1991-2)

  15. C. difficile voluntary reporting 1991 – 2005: England, Wales and Northern Ireland

  16. Mandatory surveillance 2004 - 5 • January 2004 • All NHS Trusts in England • Report all cases of C. difficile disease • Toxin +ve diarrhoea • Patients 65 years and older • Results • 2004 : 44,314 • 2005 : 51,767 • 2006 : 55,681

  17. C. difficile deaths 1999-2005 Office of National Statistics

  18. C. difficile profile 2005-07 • Public, media, politicians • HCC/HPA Survey published Dec. 2005 • NHS Trusts not following guidance • Antibiotic policies; prevention; management; infection control; reporting • Advisory letter from CMO/CNO Dec 2005 • HCC report on Stoke Mandeville July 2006 • CMO/CNO/CPhO/CEx letter Dec 2006 • Local targets April 2007

  19. How do we change bad habits? • Enhanced surveillance (HPA) • MRSA & C. difficile • Clinical practice protocols • Cleanliness and hygiene • hand hygiene • environmental cleaning • Management • emphasis on infection control • Training

  20. Improved C. difficile surveillance • Individual web entry • All patients over 2 years • Core data • Identifier; age; sex • Date of sample • Location of patient • Reporting laboratory • Started April 1, 2007

  21. C. difficile voluntary page • Risk factors • Health services contact • Antibiotic history • PPIs • Specialty • Augmented care • Suggest 2 – 4 weeks, 4 times a year? • Local assessment; national pooling

  22. Providing the tools • Cleanyourhands campaign • PEAT inspections for cleanliness • Saving Lives & Essential Steps • Root Cause Analysis tool • bacteraemia-specific version – Sept 2006 • MRSA screening advice - October 2006 • C. difficile guidance - December 2006 ……..and now…….

  23. …..legislation • Health Act 2006 • Statutory Code of Practice • Compliance assessed by the Healthcare Commission

  24. Health Act 2006 – Code of Practice • 11 core duties • Management, Organisation and Environment • Clinical Care Protocols • Healthcare Workers • Training in Infection Control • Own health protection • Policy components & references to support compliance • SL assessment revision to reflect CoP

  25. ‘Saving lives’ toolkit • Two components • Self assessment tool – based on 9 challenges now being revised to reflect CoP • 5 high Impact Interventions (Care Bundle approach) now increased to 8 plus guidance notes

  26. Self-assessment tool • Assurance statements for Core Duties (11) • 1. General duty to protect patients, staff and others from HCAI • 2. Appropriate management systems for IPC • 3. Assess risks of HCAI and take action to reduce/control • 4. Provide and maintain a clean environment • 5. Provide information to patients and public

  27. Core duties (cont.) • 6. Provide information when patients move from one healthcare provider to another • 7. Ensure cooperation within healthcare provider • 8. Provide adequate isolation facilities • 9. Ensure adequate laboratory support • 10. Adhere to policies and protocols for IPC • 11. HCW to be free from and protected from infections and to be educated in IPC

  28. High Impact Interventions • Preventing microbial contamination • Basic asepsis and hygiene • a Central venous catheters b Peripheral line care c Dialysis catheters • Surgical site management • Urinary catheters • Ventilator management • Clostridium difficile

  29. SL Guidance • MRSA screening – October 2006 • C. difficile control – CMO,CNO,CPhO,CEx letter December 2006 • Coming soon • Blood Culture protocol • Antimicrobial prescribing framework

  30. MRSA screening – October 2006 • Advisory/guidance to NHS Trusts • Focus on own high-risk groups • Elective orthopaedic, cardiovascular, neurosurgery – pre-admission • Emergency surgery – elderly orthopaedic/trauma? • All elective surgery? • ICU & HDU admission and weekly • Renal dialysis • Admissions from other hospitals, healthcare settings • All emergency admissions??

  31. Screening and decolonisation • Screening methods • Swab, direct plating on chromogenic agar • Swab, into selective broth, then plate • Rapid tests, eg PCR etc • Decolonisation regimen • MRSA positive • All initially; stop on negative result? • All, irrespective of screening? • Isolate patient if possible

  32. Objective All trusts, as a matter of urgency, should review their policies for MRSA screening to determine the most appropriate initial approach to screening for their patient population.

  33. CMO/CNO/CPhO C. difficile guidance: Dec 2006 • Antibiotic prescribing • Limit broad spectrum agents • Limit IV and oral courses • Prompt diagnostic tests – Toxins A+B • isolates for typing if outbreak suspected • Isolation/segregation/cohorting of cases • Infection control – handwashing, gloves, gowns • Decontamination/cleaning – increase • Chlorine-based disinfectant

  34. Management priority & responsibility • HCAI • NOT just the Infection Control Team • Trust Board • Chief Executive • Clinical ownership • ALL STAFF • DIPC is the focus • Responsibility • Authority – clinical and managerial • Resource allocation

  35. WW Action area 6.Management and organisation • Chief Executive’s responsibilities • Core part of Clinical Governance and Patient Safety programmes • Promote low levels of HCAI • Ensure actions are taken • Aware of legal responsibilities to identify, assess and control risks of infection • Appoint Director of Infection Prevention and Control

  36. DIPC role • Senior management – Board/CEx report • Professional credibility • Special expertise • Reporting line for ICT • Policy implementation • Performance management • Resource allocation • A champion & a manager!!

  37. Performance management • SHA performance managers • PCT local C. difficile targets 2007 • Recovery and Support Unit (DH) Task Force • MRSA & C. difficile figures • Monitors programme activities • Identifies Trusts for SL reviews and visits • Healthcare Commission • Annual assessments (scores and ratings) • National Study 2005/6 • Legislation compliance (Improvement notices)

  38. Target performance management • DH Recovery and Support Unit Task Force • Reviews MRSA bacteraemia and C. difficle figures • Monitors programme activities • Identifies Trusts for SL reviews and visits • SHA performance managers • Monthly review of Trust performance • PCT commissioners

  39. Improvement programme • National Performance Improvement Network (PIN) • Meets 4 times a year • Saving Lives self assessment reviews • Improvement visits • DH team;2-day interviews • Develop local action/recovery plan

  40. A wake-up call…….. • We have accepted these infections as ‘normal’ • Patients • Can be very ill • Can die • Stay in hospital longer • May need major surgery • Significant NHS resources could be better used

  41. Goal (Government/DH) - use • Political imperative • Measurement • Target setting • Professional support • Performance management AND • Legislation To change human behaviour (clinical & managerial) to • Overcome the biology of HCAI

More Related